Nikola shares fall following discontinuation of collaboration on garbage truck development Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Casi Pharmaceuticals (CASI) up 7% after announcing that the Chinese Center for Drug Evaluation, a division of the China National Medical Products Association, has granted Breakthrough Therapy Designation to its partner Juventas Cell Therapy for CNCT19, a potential CD19 CAR-T therapy for the treatment of adults with relapsed/refractory B-cell acute lymphoblastic leukemia
- OraSure (OSUR) up 8% after announcing its OMNIgene ORAL collection device was included in the FDA Emergency Use Authorization amendment granted to 3B BlackBio Biotech
- Ocugen (OCGN) up 150% after
announcing yesterday a binding letter of intent to co-develop Bharat Biotech's COVID-19 vaccine candidate, COVAXIN, an advanced stage whole-viron inactivated vaccine candidate, for the United States market
UP AFTER EARNINGS -
- Bridgeline Digital (BLIN) up 9%
LOWER -
- ReneSola (SOL) down 9% after entering into an agreement to sell two ground-mounted solar parks in Romania with a combined capacity of 15.4 MW and announcing a $20M registered direct offering
- Nikola (NKLA) down 9% after announcing that the company and Republic Services (RSG) have discontinued their collaboration on refuse truck development
- FuboTV (FUBO) down 11% after BMO Capital analyst Daniel Salmon downgraded shares to Market Perform from Outperform with a price target of $50, up from $33
- Voyager Therapeutics (VYGR) down 10% after that the FDA has notified Neurocrine Biosciences (NBIX) that it has placed a clinical hold on the RESTORE-1 clinical trial of NBIb-1817
- Arcturus Therapeutics (ARCT) down 9% after Roth Capital analyst Elemer Piros double downgraded the stock to Sell from Buy with an unchanged price target of $77
- Spectrum (SPPI) down 7% after announcing that its pre-specified primary endpoint in its Phase 2 clinical trial evaluating poziotinib in first-line NSCLC patients with EGFR exon 20 insertion mutations was not met in Cohort 3
Symbols:
SOL - $12.00 /
+2.515 (+26.52%)
CASI OSUR OCGN - $0.81 /
+0.5105 (+173.29%)
BLIN FUBO - $62.26 /
+12.805 (+25.89%)
VYGR ARCT SPPI NKLA RSG Keywords: Fly Intel, Wall Street, Top Stories, Stocks